As part of our Advancing Neuroendocrine Cancer Research campaign, and in collaboration with the United Kingdom & Ireland Neuroendocrine Tumour Society (UKINETS) we launched our Practice-Changing Grants in 2023. These grants aim to find new and practical...
Neuroendocrine Cancer UK is thrilled to announce the launch of our Practice-Changing Grants initiative, which is part of our Advancing Research campaign. The grants are designed to identify practical solutions that significantly enhance the well-being and experiences...
We are excited to present our latest podcast episode, where we delve into the intriguing world of quality-of-life research with a distinguished expert in the field, Professor John Ramage. Prof. Ramage is a consultant physician specialising in gastroenterology and...
We are thrilled to announce a development that brings renewed hope to the Neuroendocrine Cancer community. Ancora.ai, an innovative company at the forefront of medical technology, is transforming the landscape of clinical trial accessibility for patients with...
Neuroendocrine Cancer UK is thrilled to announce the official launch of our campaign, “Advancing Neuroendocrine Cancer Research.” This campaign aims to improve the understanding, management options, and outcomes for individuals with this complex cancer. ...
